<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="pmc-domain-id">3416</journal-id><journal-id journal-id-type="pmc-domain">molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430292</article-id><article-id pub-id-type="pmcid-ver">PMC12430292.1</article-id><article-id pub-id-type="pmcaid">12430292</article-id><article-id pub-id-type="pmcaiid">12430292</article-id><article-id pub-id-type="doi">10.3390/molecules30173624</article-id><article-id pub-id-type="publisher-id">molecules-30-03624</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Nematicide Chalcones Act Synergistically on <italic toggle="yes">Caenorhabditis elegans</italic> and <italic toggle="yes">Meloidogyne incognita</italic> Without Disrupting Soil Microbial Diversity and with Limited Toxicity to Human Cells</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7224-7078</contrib-id><name name-style="western"><surname>Calder&#243;n-Urrea</surname><given-names initials="A">Alejandro</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-molecules-30-03624" ref-type="aff">1</xref><xref rid="c1-molecules-30-03624" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shinde</surname><given-names initials="S">Shantanu</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af1-molecules-30-03624" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kendoyan</surname><given-names initials="S">Sosse</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af1-molecules-30-03624" ref-type="aff">1</xref><xref rid="af2-molecules-30-03624" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0226-1998</contrib-id><name name-style="western"><surname>Jovanovic</surname><given-names initials="VM">Vukasin M.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af3-molecules-30-03624" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ryu</surname><given-names initials="S">Seungmi</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="af3-molecules-30-03624" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tristan</surname><given-names initials="CA">Carlos A.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af3-molecules-30-03624" ref-type="aff">3</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Battino</surname><given-names initials="M">Maurizio</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Grant</surname><given-names initials="G">George</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-30-03624"><label>1</label>Department of Biology, California State University, Fresno, CA 93740, USA; <email>shantanujshinde@gmail.com</email> (S.S.); <email>soskendoyan@mail.fresnostate.edu</email> (S.K.)</aff><aff id="af2-molecules-30-03624"><label>2</label>Department of Biology, Madera Community College, Madera, CA 93638, USA</aff><aff id="af3-molecules-30-03624"><label>3</label>Stem Cell Translation Laboratory (SCTL), National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), 9800 Medical Center Drive, Rockville, MD 20850, USA; <email>vukasin.jovanovic@nih.gov</email> (V.M.J.); <email>seungmi.ryu@nih.gov</email> (S.R.); <email>carlos.tristan@nih.gov</email> (C.A.T.)</aff><author-notes><corresp id="c1-molecules-30-03624"><label>*</label>Correspondence: <email>calalea@csufresno.edu</email>; Tel.: +1-559-278-4080</corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>30</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">496502</issue-id><elocation-id>3624</elocation-id><history><date date-type="received"><day>16</day><month>7</month><year>2025</year></date><date date-type="rev-recd"><day>26</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>03</day><month>9</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>05</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 11:25:14.803"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="molecules-30-03624.pdf"/><abstract><p>Plant Parasitic Nematodes (PPNs), such as <italic toggle="yes">Meloidogyne incognita</italic>, cause significant agricultural losses worldwide. Conventional nematicides like methyl bromide are being phased out due to environmental and health concerns, prompting the search for safer alternatives. In previous studies, chalcones <bold>17</bold>, <bold>25</bold>, and <bold>30</bold>, flavonoid compounds, were shown to effectively kill the model nematode <italic toggle="yes">Caenorhabditis elegans</italic> at concentrations of 10<sup>&#8722;4</sup> M. However, the potential of these chalcones to act synergistically at lower concentrations has not been explored. In this study, the nematicidal efficacy of chalcones <bold>17</bold>, <bold>25</bold>, and <bold>30</bold> was evaluated individually and in combination at concentrations as low as 10<sup>&#8722;6</sup> M. The results demonstrate a strong synergistic effect, with combinations achieving 90&#8211;100% mortality in <italic toggle="yes">C. elegans</italic> within 3 days. Additionally, the combination index method revealed significant toxic effects against <italic toggle="yes">M. incognita</italic> with chalcones <bold>17</bold> and <bold>30</bold> in binary and ternary combinations. To assess the effects of these chalcones on nontarget organisms, chalcones were also tested for antimicrobial activity against soil bacteria; analysis of soil microbiota using 16S rRNA sequencing indicated that chalcones did not significantly disrupt microbial populations. Furthermore, tests on human pluripotent stem cells (hPSCs) reveal no major effects on the viability of these cells at concentrations as high as the concentrations needed to kill nematodes. These findings highlight the potential of chalcones <bold>17</bold>, <bold>25</bold>, and <bold>30</bold> for effective nematode control without harming soil bacteria or human cells.</p></abstract><kwd-group><kwd>synergistic effects</kwd><kwd>chalcone combinations</kwd><kwd>control of PPN (Plant Parasitic Nematodes)</kwd><kwd>pesticide safety</kwd><kwd>pesticides and alteration of soil microbiota</kwd></kwd-group><funding-group><award-group><funding-source>the National Institute of Health (NIH)</funding-source><award-id>R16GM145429</award-id></award-group><award-group><funding-source>the National Center for Advancing Translational Sciences (NCATS)</funding-source></award-group><award-group><funding-source>the Dean of the College of Science and Mathematics at California State University</funding-source></award-group><funding-statement>This research was partially funded by the National Institute of Health (NIH), grant number R16GM145429 to A.C.-U., and the intramural research program of the National Center for Advancing Translational Sciences (NCATS). Funding was also provided by the Dean of the College of Science and Mathematics at California State University, Fresno.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-30-03624"><title>1. Introduction</title><p>Nematodes, commonly known as roundworms, represent one of the most diverse animal phyla, with an estimated 28,000 described species, of which over 16,000 are parasitic [<xref rid="B1-molecules-30-03624" ref-type="bibr">1</xref>]. Among these, plant-parasitic nematodes (PPNs) are of particular significance, as they inflict devastating damage to global agriculture. Annual crop losses attributed to PPNs are estimated to reach $125 billion, underscoring their economic and ecological impact [<xref rid="B2-molecules-30-03624" ref-type="bibr">2</xref>]. Among PPNs, <italic toggle="yes">M. incognita</italic> is a significant agricultural pest infecting a broad range of crop species and causing substantial economic losses [<xref rid="B3-molecules-30-03624" ref-type="bibr">3</xref>]. This obligatory parasite infects the roots of a wide range of host plants, causing the formation of characteristic galls at feeding sites. These galls result from the transformation of plant cells into multinucleate giant cells, which serve as the nematode&#8217;s sole nutrient source [<xref rid="B4-molecules-30-03624" ref-type="bibr">4</xref>]. The life cycle of <italic toggle="yes">M. incognita</italic> begins with second-stage juveniles (J2), which hatch from eggs under favorable conditions and invade host plant roots [<xref rid="B5-molecules-30-03624" ref-type="bibr">5</xref>]. The development and proliferation of these nematodes severely compromise plant health, reducing yield and quality.</p><p>Control strategies for PPNs have historically relied on chemical nematicides, crop rotations, thermal treatments, and breeding resistant cultivars [<xref rid="B6-molecules-30-03624" ref-type="bibr">6</xref>]. However, the widespread use of chemical nematicides has raised significant environmental and public health concerns. For instance, compounds such as 1,2-dibromo-3-chloropropane (DBCP) and ethylene dibromide were withdrawn from markets due to their deleterious effects on human health and the environment [<xref rid="B7-molecules-30-03624" ref-type="bibr">7</xref>]. Similarly, aldicarb, a highly toxic nematicide, has been detected in groundwater, raising alarms about its safety [<xref rid="B8-molecules-30-03624" ref-type="bibr">8</xref>]. Methyl bromide, once a widely used fumigant, was found to be a potent ozone-depleting substance, leading to its phase-out under international agreements [<xref rid="B9-molecules-30-03624" ref-type="bibr">9</xref>].</p><p>Given these challenges, the search for sustainable and environmentally friendly alternatives to synthetic chemical nematicides has gained momentum. Natural products, such as chalcones, have emerged as promising candidates for nematode control. Chalcones, precursors in the flavonoid biosynthetic pathway, are naturally occurring compounds known for their diverse biological activities, including antibacterial, antitumor, antimalarial, antioxidant, and nematicidal effects [<xref rid="B10-molecules-30-03624" ref-type="bibr">10</xref>]. Various studies have demonstrated the efficacy of chalcones against PPNs. For example, trans-1,3-diphenylpropenone (E-chalcone) has shown 100% lethality against <italic toggle="yes">Globodera pallida</italic> and <italic toggle="yes">G. rostochiensis</italic> at concentrations below 50 &#181;M [<xref rid="B11-molecules-30-03624" ref-type="bibr">11</xref>]. Similarly, chalcone derivatives have exhibited potent nematicidal activity against other nematode species, such as <italic toggle="yes">Bursaphelenchus xylophilus</italic> [<xref rid="B12-molecules-30-03624" ref-type="bibr">12</xref>]. More recently, studies using <italic toggle="yes">Caenorhabditis elegans</italic> as a model organism have provided insights into the nematicidal properties of chalcones. Work from our laboratory has demonstrated that certain organic chalcones can induce 100% lethality in <italic toggle="yes">C. elegans</italic> at micromolar concentrations [<xref rid="B13-molecules-30-03624" ref-type="bibr">13</xref>]. Moreover, the lipophilicity of chalcones appears to play a critical role in their nematicidal activity, influencing their ability to penetrate nematode cell membranes. <italic toggle="yes">C. elegans</italic> serves as an ideal model for studying nematicidal activity due to its well-characterized biology, rapid life cycle, and ease of maintenance in laboratory settings.</p><p>The concept of chemical synergy, wherein the combined effect of multiple compounds exceeds the sum of their individual effects, has garnered attention in nematicidal research [<xref rid="B14-molecules-30-03624" ref-type="bibr">14</xref>]. Synergistic interactions can enhance the efficacy of nematicidal agents while minimizing the required dosages, thereby reducing environmental impact. However, genuine synergistic interactions are relatively rare and often concentration-dependent [<xref rid="B15-molecules-30-03624" ref-type="bibr">15</xref>].</p><p>Studies in Dr. Calder&#243;n-Urrea&#8217;s lab have indicated that chalcones <bold>17</bold>, <bold>25</bold>, and <bold>30</bold> [see <xref rid="molecules-30-03624-f001" ref-type="fig">Figure 1</xref>. Chalcone <bold>17</bold>: (2E)-1-(2,4-Dichlorophenyl)-3-phenyl-2-propen-1-one; Chalcone <bold>25</bold>: (2E)-1-(4-Ethoxyphenyl)-3-phenyl-2-propen-1-one; and Chalcone <bold>30</bold>: (2E)-3-Phenyl-1-(2-thienyl)-2-propen-1-one] exhibit nematicidal effects at concentrations of 10<sup>&#8722;4</sup> M [<xref rid="B13-molecules-30-03624" ref-type="bibr">13</xref>]. Preliminary findings indicate that these chalcones have effects at even lower concentrations (10<sup>&#8722;5</sup> M), and when combined achieve near-complete lethality in <italic toggle="yes">C. elegans</italic> and <italic toggle="yes">M. incognita</italic>, suggesting potential synergistic interactions.</p><p>The combination index (CI) equation, based on the median-effect equation, provides a quantitative framework for evaluating such interactions [<xref rid="B16-molecules-30-03624" ref-type="bibr">16</xref>]. This study aims to investigate the nature of interactions between chalcones <bold>17</bold>, <bold>25</bold>, and <bold>30</bold>, focusing on their effects on <italic toggle="yes">C. elegans</italic> and <italic toggle="yes">M. incognita</italic>. We hypothesize that the combined use of chalcones <bold>17</bold>, <bold>25</bold>, and <bold>30</bold> will exhibit a synergistic effect, resulting in enhanced lethality against both nematode species. By addressing these hypotheses, this study aims to provide insights into the potential of chalcone-based formulations as environmentally friendly nematicidal alternatives.</p><p>Soil is one of Earth&#8217;s most biologically diverse environments, hosting an array of microorganisms that play essential roles in nutrient cycling, organic matter decomposition, and maintaining soil quality [<xref rid="B17-molecules-30-03624" ref-type="bibr">17</xref>]. The composition and diversity of soil microorganisms vary with location, vegetation, and resource availability. This variability underscores the importance of assessing the impact of chalcone treatments on specific microbial communities in soils affected by PPNs. Introducing chalcones into these systems could alter microbial diversity and abundance, potentially affecting soil quality and health [<xref rid="B18-molecules-30-03624" ref-type="bibr">18</xref>]. Therefore, this study also aims to evaluate the effects of chalcones&#8212;<bold>17</bold>, <bold>25</bold>, and <bold>30</bold>&#8212;and their equimolar combinations on soil microbial communities. By evaluating the impact of chalcones on soil microorganisms, this study aims to determine whether these compounds can provide sustainable nematode control without compromising soil health. The findings will inform future risk assessments and guide the development of environmentally friendly pest management strategies. Finally, the chalcones were tested for cytotoxicity on two human pluripotent stem cells (hPSCs) revealing no major effects on the viability of these cells at concentrations as high as the concentrations needed to kill nematodes.</p></sec><sec sec-type="results" id="sec2-molecules-30-03624"><title>2. Results</title><sec id="sec2dot1-molecules-30-03624"><title>2.1. Nematicidal Activity and Synergistic Interactions of Chalcones in C. elegans</title><p>To evaluate the nematicidal effects of chalcones, compounds <bold>17</bold>, <bold>25</bold>, and <bold>30</bold> were assessed individually and in combinations for their ability to induce mortality in <italic toggle="yes">Caenorhabditis elegans</italic> after a 3-day exposure. Dose&#8211;response lethality tests identified approximate LD<sub>30</sub> concentrations (dose treatment that will be lethal to approximately 30% of the population) for each chalcone by establishing concentration&#8211;mortality curves across 10<sup>&#8722;4</sup> M to 10<sup>&#8722;6</sup> M. Chalcones exhibited increasing mortality with higher concentrations, allowing LD<sub>30</sub> identification in the 2&#8211;8 &#181;M range. Chalcone <bold>17</bold> had LD<sub>30</sub> values yielding 33&#8211;40% mortality, while chalcone <bold>25</bold> and chalcone <bold>30</bold> showed mortality in the 21&#8211;38% and 21&#8211;29% ranges, respectively (<xref rid="molecules-30-03624-f002" ref-type="fig">Figure 2</xref>).</p><p>Subsequently, pairwise (<bold>17</bold> + <bold>25</bold>, <bold>25</bold> + <bold>30</bold>, <bold>17</bold> + <bold>30</bold>) and ternary (<bold>17</bold> + <bold>25</bold> + <bold>30</bold>) combinations were tested at LD<sub>30</sub> concentrations. If effects were additive, a ~60% mortality was expected. However, all combinations displayed synergistic interactions with mortality rates &#8805; 93% and as high as 100%, significantly exceeding additive expectations (<xref rid="molecules-30-03624-t001" ref-type="table">Table 1</xref>). Notably, the <bold>17</bold> + <bold>25</bold> combination at 8 &#181;M yielded 97% mortality, confirming strong synergistic interactions. Mortality remained above 93% across all combinations even at 0.1 &#181;M. The control (M9 buffer) mortality was &lt; 20% (mean of all mixtures was 8% with a mean standard deviation of 0.023%), supporting the conclusion that the chalcone-induced effects were specific and significant.</p></sec><sec id="sec2dot2-molecules-30-03624"><title>2.2. Nematicidal Activity in Meloidogyne incognita</title><p>Chalcones <bold>17</bold>, <bold>25</bold>, and <bold>30</bold> were also evaluated for lethality in <italic toggle="yes">M. incognita</italic>, a major plant-parasitic nematode. At concentrations between 20 and 100 &#181;M, all chalcones exhibited 100% lethality by day 5 post-treatment (<xref rid="molecules-30-03624-f003" ref-type="fig">Figure 3</xref> and <xref rid="molecules-30-03624-t002" ref-type="table">Table 2</xref>). Similarly to <italic toggle="yes">C. elegans</italic>, combinations of chalcones were tested. Synergistic lethality (&gt;99%) was observed in combinations <bold>17</bold> + <bold>25</bold> + <bold>30</bold>, <bold>25</bold> + <bold>30</bold>, and <bold>17</bold> + <bold>30</bold> at concentrations of 4&#8211;10 &#181;M. The <bold>17</bold> + <bold>25</bold> combination showed 100% lethality only at 10 &#181;M and dropped below 90% at lower concentrations (<xref rid="molecules-30-03624-t002" ref-type="table">Table 2</xref>).</p><p>To quantify the interaction effects, combination index (CI) values were calculated using the median-effect equation. Chalcone <bold>17</bold> had the lowest LD<sub>50</sub> (0.52866 &#181;M), indicating highest potency, while chalcone <bold>25</bold> had the highest LD<sub>50</sub> (2.69874 &#181;M). CI values confirmed synergism (CI &lt; 1) in most combinations and concentrations, with a mild additive effect (CI &#8776; 0.98) for 17 + 25 only at 1 &#181;M. CI values across LD<sub>30</sub> to LD<sub>95</sub> showed consistent synergistic trends (<xref rid="molecules-30-03624-t003" ref-type="table">Table 3</xref> and <xref rid="molecules-30-03624-t004" ref-type="table">Table 4</xref>). Polygonogram analysis supported these findings, with clear synergistic interactions observed across combinations and fractional effect levels (<xref rid="molecules-30-03624-f004" ref-type="fig">Figure 4</xref>).</p></sec><sec id="sec2dot3-molecules-30-03624"><title>2.3. Effects of Chalcones on Soil Bacterial Microbiota</title><p>To assess ecological safety, the effects of chalcones on soil microbiota were evaluated via 16S rRNA sequencing of samples treated with individual and combined chalcones. Alpha and beta diversity analyses were employed to characterize the microbial community structure across samples. Alpha diversity metrics provide insight into the diversity within individual samples. Two commonly used measures were applied in this study: (i) Observed OTUs, which quantify the total number of distinct operational taxonomic units (OTUs) detected, reflecting community richness without considering relative abundance (analogous to counting the number of different book titles in a library, irrespective of the number of copies), where higher values indicate a greater variety of microbial taxa; and (ii) the Shannon Diversity Index, which integrates both richness and evenness, such that higher values denote communities with a wide range of taxa distributed in a relatively balanced manner. To assess differences between microbial communities across samples, beta diversity metrics were calculated. Bray&#8211;Curtis dissimilarity was used to account for both species presence/absence and their relative abundances, with values ranging from 0 (identical communities) to 1 (completely distinct communities). Non-metric multidimensional scaling (NMDS) ordination was subsequently employed to visualize these differences, with samples plotted as points such that those in closer proximity represent more compositionally similar microbial communities, while those farther apart reflect greater dissimilarity.</p><p>Alpha diversity metrics, including observed Operational Taxonomic Unit (OTUs) and Shannon diversity index, showed minimal disruption compared to untreated or Fluopyram-treated controls (<xref rid="molecules-30-03624-f005" ref-type="fig">Figure 5</xref>, <xref rid="molecules-30-03624-t005" ref-type="table">Table 5</xref> and <xref rid="molecules-30-03624-t006" ref-type="table">Table 6</xref>). The untreated sample had the highest OTU count (2563 &#177; 55), with chalcone <bold>17</bold> (2407 &#177; 105) and Fluopyram (2404 &#177; 104) closely following. Among combinations, <bold>17</bold> + <bold>30</bold> and <bold>17</bold> + <bold>25</bold> + <bold>30</bold> preserved relatively high OTU diversity.</p><p>Shannon index values remained largely consistent across treatments, with the highest values in untreated soil (6.73 &#177; 0.06) and Fluopyram (6.66 &#177; 0.04), and slightly lower diversity observed in <bold>17</bold> + <bold>25</bold> (6.36 &#177; 0.42). Kruskal&#8211;Wallis pairwise comparisons revealed statistically significant differences (<italic toggle="yes">p</italic> &lt; 0.05) in Shannon diversity for <bold>17</bold> + <bold>25</bold> + <bold>30</bold> vs. <bold>17</bold>, Fluopyram, and untreated samples, as well as between untreated samples and several other treatments (<xref rid="molecules-30-03624-t007" ref-type="table">Table 7</xref>).</p><p>Beta diversity assessed via NMDS ordination of Bray&#8211;Curtis dissimilarities (<xref rid="molecules-30-03624-f006" ref-type="fig">Figure 6</xref>) showed minimal shifts in microbial community composition. Temporal effects were minor and comparable across treatments. PERMANOVA analysis confirmed no significant differences between groups (<italic toggle="yes">p</italic> = 0.648), supporting the conclusion that chalcones do not induce major microbiome disruption.</p></sec><sec id="sec2dot4-molecules-30-03624"><title>2.4. Cytotoxicity of Chalcones in hPSCs</title><p>To investigate potential toxicity in human cells, two hPSC lines (WA09 and NCRM5) were treated with chalcones across a concentration range of 1 nM to 100 &#181;M, and cell viability evaluated using the CellTiter-Glo (CTG) assay, which quantifies intracellular ATP as a surrogate for metabolically active, viable cells. All three chalcones were well tolerated up to 1 &#181;M, with cytotoxic effects becoming evident only at 10 and 100 &#181;M (<xref rid="molecules-30-03624-f007" ref-type="fig">Figure 7</xref>A). Furthermore, the <bold>17</bold> + <bold>30</bold> combination, effective in nematodes at micromolar concentrations (&#8804; 1 &#181;M), was tested at 0, 10 nM, 100 nM, and 1 &#181;M, and given that toxicity emerged in hPSCs above 1 &#181;M, we restricted testing to 1 &#181;M and below to ensure rigorous evaluation within its safe window in hPSCs. Cell viability remained unaffected, with only a minor reduction observed in NCRM5 at 10 nM (<xref rid="molecules-30-03624-f007" ref-type="fig">Figure 7</xref>B).</p></sec></sec><sec sec-type="discussion" id="sec3-molecules-30-03624"><title>3. Discussion</title><p>This study provides a preliminary evaluation of the nematicidal potential, synergistic interactions, environmental safety, and cytotoxicity profile of three structurally related chalcones&#8212;<bold>17</bold>, <bold>25</bold>, and <bold>30</bold>&#8212;highlighting their promise as next-generation biopesticides. With growing concerns about food security and the ecological harm posed by traditional chemical nematicides, the need for effective and environmentally benign alternatives is increasingly critical [<xref rid="B14-molecules-30-03624" ref-type="bibr">14</xref>]. Our findings provide preliminary evidence that these chalcones possess, nematode-specific lethality at low concentrations and exhibit enhanced efficacy when used in synergistic combinations, while exerting negligible effects on non-target organisms such as soil microbiota and hPSCs at concentration below 1 &#181;M.</p><sec id="sec3dot1-molecules-30-03624"><title>3.1. Synergistic Nematicidal Activity</title><p>It has been argued for a long time that the combination of insecticides with different modes of action is advantageous in integrated pest management (IPM) programs [<xref rid="B20-molecules-30-03624" ref-type="bibr">20</xref>,<xref rid="B21-molecules-30-03624" ref-type="bibr">21</xref>]. The synergistic lethality of chalcone combinations against both <italic toggle="yes">Caenorhabditis elegans</italic> and <italic toggle="yes">Meloidogyne incognita</italic> is a major highlight of this work. Individually, each chalcone was capable of inducing 100% mortality at 100 &#181;M. However, combinations&#8212;particularly at lower micromolar levels (&#8804;10 &#181;M)&#8212;demonstrated markedly enhanced efficacy, frequently achieving mortality rates exceeding 90%. This synergism, confirmed by combination index (CI) analysis, suggests interactions that may involve distinct cellular targets or uptake pathways.</p><p>Effect-level dependency was evident in CI analysis: while some combinations (e.g., <bold>25</bold> + <bold>30</bold>) exhibited consistent synergy across all fractional effect (fa) levels, others (e.g., <bold>17</bold> + <bold>25</bold>, <bold>17</bold> + <bold>30</bold>, <bold>17</bold> + <bold>25</bold> + <bold>30</bold>) displayed a dual synergistic/antagonistic behavior, with antagonism at lower fa levels transitioning to synergy at fa &gt; 0.6. These results underscore the importance of dosage context and support the rationale for using combination formulations to reduce active ingredient load while maintaining efficacy&#8212;an approach aligned with integrated pest management (IPM) principles [<xref rid="B14-molecules-30-03624" ref-type="bibr">14</xref>].</p></sec><sec id="sec3dot2-molecules-30-03624"><title>3.2. Mechanistic Considerations</title><p>The precise mechanisms driving the synergistic toxicity remain to be elucidated, but may involve interactions affecting uptake, metabolism, or target binding. Previous studies have shown that chemical interactions can alter bioavailability, intracellular distribution, and elimination, thereby shaping toxicity profiles [<xref rid="B15-molecules-30-03624" ref-type="bibr">15</xref>,<xref rid="B22-molecules-30-03624" ref-type="bibr">22</xref>]. Others have shown that possible mechanisms of action involve the inhibition of P450 enzyme, which plays a critical role in the oxidation of several substances within the nematode [<xref rid="B23-molecules-30-03624" ref-type="bibr">23</xref>]. The observed species-specific differences&#8212;robust synergy in <italic toggle="yes">C. elegans</italic> versus more variable responses in <italic toggle="yes">M. incognita</italic>&#8212;highlight the importance of test system selection and the need for broader cross-species analyses. Further studies employing molecular and genetic tools will be necessary to identify chalcone targets and to dissect the biochemical pathways implicated in nematode mortality.</p></sec><sec id="sec3dot3-molecules-30-03624"><title>3.3. Ecological Compatibility</title><p>Sustainable pest control strategies must avoid compromising soil health [<xref rid="B24-molecules-30-03624" ref-type="bibr">24</xref>]. Our 16S rRNA-based microbiota analysis revealed that chalcone treatments&#8212;alone or in combination&#8212;did not significantly alter alpha (Shannon index) or beta (Bray&#8211;Curtis) diversity of soil bacterial communities. These findings suggest that the nematicidal effects of chalcones are highly selective, sparing the broader microbial ecosystem. While minor reductions in diversity were noted in certain treatments (e.g., <bold>17</bold> + <bold>25</bold> + <bold>30</bold>), they did not exceed thresholds of statistical or ecological concern (PERMANOVA <italic toggle="yes">p</italic> &gt; 0.05).</p><p>Interestingly, a slight, non-significant enrichment of <italic toggle="yes">Pseudomonas</italic> species was observed. Given the dual role of <italic toggle="yes">Pseudomonas</italic> strains as both pathogens and plant growth promoters, further taxonomic resolution is warranted. Nevertheless, the limited ecological disruption seen here supports the compatibility of chalcones with long-term soil fertility and microbial function.</p></sec><sec id="sec3dot4-molecules-30-03624"><title>3.4. Cytotoxicity and Human Health Implications</title><p>Human toxicity is a critical consideration in biopesticide development [<xref rid="B25-molecules-30-03624" ref-type="bibr">25</xref>]. Our assessment using two independent hPSC lines showed that chalcones, even at concentrations lethal to nematodes, exhibited minimal cytotoxicity, with only slight reductions in viability observed at the highest tested doses. This selective toxicity profile compares favorably with legacy nematicides such as DBCP and ethylene dibromide, which are associated with significant human health risks including carcinogenicity and reproductive toxicity.</p><p>The absence of observed toxicity from the chalcones, alone or in combination, on hPSCs at concentrations below 1 &#956;M suggests a promising safety margin. However, a more comprehensive toxicity evaluation encompassing gene expression profiling, differentiation potential, and stress responses assays in hPSC-derived organoids and tissue models would further enhance our confidence on their safety profile and potentially provide insight toward the minimal but significant effects in viability observed in the NCRM5 hPSC line at 10 nM when treated with the <bold>17</bold> + <bold>30</bold> combination.</p></sec><sec id="sec3dot5-molecules-30-03624"><title>3.5. Limitations and Future Directions</title><p>While our findings support the efficacy and safety of chalcone-based nematicides, several limitations merit consideration. First, mechanistic studies are needed to elucidate the molecular targets of each chalcone and their interactions. Second, field trials in crop systems are required to validate efficacy under variable environmental conditions and to assess stability and degradation profiles. Additionally, long-term ecological studies&#8212;including impacts on non-target fauna and trophic interactions&#8212;will be essential to comprehensively establish environmental safety.</p><p>Finally, formulation development to enhance solubility, bioavailability, and delivery to target organisms will be key to transitioning chalcones from lab-scale evaluation to practical agricultural use.</p></sec></sec><sec id="sec4-molecules-30-03624"><title>4. Materials and Methods</title><sec id="sec4dot1-molecules-30-03624"><title>4.1. C. elegans Culture and Chalcone Preparation</title><sec id="sec4dot1dot1-molecules-30-03624"><title>4.1.1. <italic toggle="yes">C. elegans</italic> Strains and Maintenance</title><p><italic toggle="yes">Caenorhabditis elegans</italic> strains were provided by the Caenorhabditis Genetics Center [CGC <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://cgc.umn.edu/">https://cgc.umn.edu/</uri> (accessed on 4 September 2025)], which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). Wild-type <italic toggle="yes">C. elegans</italic> and the GFP-expressing strain PD4251 were cultured on nematode growth medium (NGM) agar seeded with <italic toggle="yes">Escherichia coli</italic> OP50. NGM plates were prepared by autoclaving a solution containing 17 g Difco<sup>&#174;</sup> agar, 12.5 g peptone, and 3 g NaCl per liter. After autoclaving, sterile additives included 1 mL cholesterol (5 mg/mL in ethanol), 1 mL 1 M CaCl<sub>2</sub>, 1 mL 1 M MgSO<sub>4</sub>, 1 mL 2 mg/mL uracil, and 25 mL 1 M potassium phosphate buffer (pH 6.0).</p></sec><sec id="sec4dot1dot2-molecules-30-03624"><title>4.1.2. Chalcone Stock Solutions and Dilution Series</title><p>Chalcones <bold>17</bold>, <bold>25</bold>, and <bold>30</bold> [synthesized as described [<xref rid="B13-molecules-30-03624" ref-type="bibr">13</xref>] were each dissolved in dimethyl sulfoxide (DMSO) to obtain 0.1 M stock solutions. Serial dilutions were prepared by stepwise dilution in ethanol and M9 buffer, yielding final test concentrations ranging from 100 &#181;M (10<sup>&#8722;4</sup> M) to 1 &#181;M (10<sup>&#8722;6</sup> M). The final solvent concentrations were maintained below 0.1% DMSO and 5% ethanol to avoid toxicity to nematodes.</p></sec></sec><sec id="sec4dot2-molecules-30-03624"><title>4.2. M. incognita Culture and Juvenile Isolation</title><sec><title>Greenhouse Cultivation and Nematode Extraction</title><p>Tomato (<italic toggle="yes">Solanum lycopersicum</italic> cv. Moneymaker) plants were grown in sterilized sand and inoculated with <italic toggle="yes">M. incognita</italic>-infected roots. After 8&#8211;10 weeks, roots were harvested, chopped, and treated with 0.8% NaClO to release eggs, which were then isolated via sucrose flotation. Hatched second-stage juveniles (J2s) were collected using sterile hatching chambers with Kimwipe overlays and maintained at 25&#8211;27 &#176;C until use.</p></sec></sec><sec id="sec4dot3-molecules-30-03624"><title>4.3. Lethality Assays for Chalcones</title><sec id="sec4dot3dot1-molecules-30-03624"><title>4.3.1. Single and Combination Treatments</title><p>96-well plate assays were performed using synchronized L3&#8211;L4 stage <italic toggle="yes">C. elegans</italic> or <italic toggle="yes">M. incognita</italic> J2s. For <italic toggle="yes">C. elegans</italic>, each well contained ~3 worms (picked nematodes from a healthy culture growing on OP50) and 100 &#181;L of chalcone solution; in each experiment a minimum of 24 nematodes were treated. For <italic toggle="yes">M. incognita</italic>, ~50 J2s were exposed per well. Chalcones were tested singly and in combinations (<bold>17</bold> + <bold>25</bold>, <bold>25</bold> + <bold>30</bold>, <bold>17</bold> + <bold>30</bold>, <bold>17</bold> + <bold>25</bold> + <bold>30</bold>) at concentrations between 1 and 10 &#181;M, chosen based on individual LD<sub>30</sub> values. All assays (experiments) were performed in triplicate, and the mean and standard deviation of at least three trials were calculated for each treatment.</p></sec><sec id="sec4dot3dot2-molecules-30-03624"><title>4.3.2. Viability Assessment</title><p><italic toggle="yes">C. elegans</italic>: Viability was determined via GFP fluorescence under a microscope; intact GFP localization indicated viability, while diffused GFP indicated mortality. <italic toggle="yes">M. incognita</italic>: Viability was assessed based on morphology and motility; dead worms appeared straight and immobile, while live worms showed active movement.</p></sec></sec><sec id="sec4dot4-molecules-30-03624"><title>4.4. Combination Index and Synergy Analysis</title><p>The median-effect principle and combination index (CI) were used to quantify synergism, antagonism, or additive effects using CompuSyn 3.0.1 software (Combosyn Inc., Paramus, NJ, USA); see <xref rid="app1-molecules-30-03624" ref-type="app">Figure S1</xref> for the CompuSyn Report. Dose-effect curves were generated, and CI values were calculated at multiple effect levels (e.g., LD<sub>30</sub>, LD<sub>50</sub>, LD<sub>90</sub>). CI &lt; 1 indicates synergy; CI = 1, additivity; and CI &gt; 1, antagonism.</p></sec><sec id="sec4dot5-molecules-30-03624"><title>4.5. Effect of Chalcones on Soil Microbiota</title><sec id="sec4dot5dot1-molecules-30-03624"><title>4.5.1. Experimental Design</title><p>To assess the ecological impact of chalcones, soil samples infected with <italic toggle="yes">M. incognita</italic> were treated with chalcones <bold>17</bold>, <bold>25</bold>, <bold>30</bold>, and their combinations at 10 &#181;M in a greenhouse setting. Treatments included, untreated samples (no treatment), solvent controls (control), NIMITZ<sup>&#174;</sup> (ADAMA Ltd., Ashdod, Israel) and Fluopyram (Bayer AG, Leverkusen, Germany). Soil samples were collected at 0, 48, and 96 h post-treatment.</p></sec><sec id="sec4dot5dot2-molecules-30-03624"><title>4.5.2. PMA Treatment and DNA Extraction</title><p>To distinguish viable cells, soil samples were treated with propidium monoazide (PMA) prior to DNA extraction. DNA was extracted using the MoBio PowerSoil<sup>&#174;</sup> kit (QIAGEN, Germantown, MD, USA). Positive and negative controls included a known microbial community mixture and sterile soil.</p></sec><sec id="sec4dot5dot3-molecules-30-03624"><title>4.5.3. 16S rRNA Gene Sequencing and Microbiota Analysis</title><p>V4 regions of the 16S rRNA gene were amplified (using 515F-GTGCCAGCMGCCGCGGTAA and 806R-GGACTACHVGGGTWTCTAAT primers) and sequenced on the Illumina MiSeq platform (San Diego, CA, USA). QIIME2 version 2018.11 [<xref rid="B26-molecules-30-03624" ref-type="bibr">26</xref>] was used to analyze alpha diversity (Shannon index, observed OTUs) and beta diversity (Bray&#8211;Curtis distances). Statistical significance was assessed using PERMANOVA.</p></sec></sec><sec id="sec4dot6-molecules-30-03624"><title>4.6. Effect of Chalcones on hPSC</title><sec><title>hPSC Cell Culture</title><p>hPSC lines WA09 and NCRM5 were cultured under feeder-free conditions in Essential 8 medium (A1517001, ThermoFisher, Waltham, MA, USA), on recombinant vitronectin (ThermoFisher, A14700) coated multi-well plates. When cells reached 70&#8211;80% confluency, cells were passaged using 0.5 mM EDTA (15575020ThermoFisher, Waltham, MA, USA) in phosphate-buffered saline at plating densities ranging from 25,000&#8211;50,000 cells per cm<sup>2</sup> in E8 media supplemented with CEPT as previously described [<xref rid="B27-molecules-30-03624" ref-type="bibr">27</xref>]. Twenty-four hours later, plating media was replaced with E8. The next day cells received a second media change and were treated with chalcones at the concentrations noted above. Twenty-four hours after treatment with chalcones, cell viability was measured using the CellTiter-Glo luminescent cell viability assay (G7570; Promega, Madison, WI, USA), according to the manufacturer&#8217;s recommendations.</p></sec></sec></sec><sec sec-type="conclusions" id="sec5-molecules-30-03624"><title>5. Conclusions</title><p>Chalcones <bold>17</bold>, <bold>25</bold>, and <bold>30</bold> exhibit synergistic nematicidal activity at concentrations of approximately 12 &#181;M (for example for the <bold>17</bold> + <bold>30</bold> combination), which can be considered as moderately potent. However, this is with minimal adverse effects on soil microbiota and human cells. These properties position them as promising candidates for sustainable, selective, and environmentally responsible biocontrol agents when used in combination; combinatorial use might also prevent the development of resistance against the chalcones. Their use could represent a significant advance in nematode management, reducing dependence on synthetic nematicides and contributing to safer agricultural practices.</p></sec><sec id="sec6-molecules-30-03624"><title>6. Patents</title><p>US Pat No. 10,925,286 B2. Synergistic chalcone containing composition of a nematicide. February 23rd, 2021. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://patents.google.com/patent/US10925286B2/en?oq=10925286">https://patents.google.com/patent/US10925286B2/en?oq=10925286</uri> (accessed on 4 September 2025).</p><p>US Pat No 11,369,111 B2. Synergistic composition of nematicide comprising chalcones. June 28th, 2022. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://patents.google.com/patent/US11369111B2/en?oq=US+Pat+No+11%2c369%2c111+B2">https://patents.google.com/patent/US11369111B2/en?oq=US+Pat+No+11%2c369%2c111+B2</uri> (accessed on 4 September 2025).</p></sec></body><back><ack><title>Acknowledgments</title><p>Thanks to Karine Gousset and Mamta Rawat for critically reading of this manuscript. Thanks to Diego Calderon for help with <xref rid="molecules-30-03624-f004" ref-type="fig">Figure 4</xref>. During the preparation of this manuscript/study, the author(s) used ChatGPT 4.5 (OpenAI, Inc., San Francisco, CA, USA) for the purposes of summarizing text, formatting text to follow <italic toggle="yes">Molecules</italic> standards, and make correct use of the English language. The authors have reviewed and edited the output and take full responsibility for the content of this publication. The contribution of the NIH authors was made as part of their official duties as NIH federal employees, are in compliance with agency policy requirements, and are considered Works of the United States Government. However, the findings and conclusions presented in this paper are those of the authors and do not necessarily reflect the views of the NIH of the U.S. Department of Health and Human Services.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-molecules-30-03624"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mdpi.com/article/10.3390/molecules30173624/s1">https://www.mdpi.com/article/10.3390/molecules30173624/s1</uri>, Figure S1: CompuSyn Report.</p><supplementary-material id="molecules-30-03624-s001" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-30-03624-s001.zip" position="float" orientation="portrait"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, A.C.-U.; methodology, A.C.-U., S.S., S.K., V.M.J., S.R., and C.A.T.; formal analysis, A.C.-U., S.S., S.K., V.M.J., S.R., and C.A.T.; investigation, A.C.-U., S.S., S.K., V.M.J., S.R., and C.A.T.; resources, A.C.-U. and C.A.T.; data curation, A.C.-U., V.M.J., and S.R.; writing&#8212;original draft preparation, A.C.-U., S.K., and S.S.; writing&#8212;review and editing, A.C.-U., S.S., S.K., V.M.J., S.R., and C.A.T.; visualization, A.C.-U., S.K., S.S., and C.A.T.; supervision, A.C.-U. and C.A.T.; project administration, A.C.-U.; funding acquisition, A.C.-U. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The original metagenomic data presented in the study are openly available through NCBI under BioProject PRJNA1293377.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>A.C.-U. is the founder and Chief Scientific Officer of Telluris Biotech India Private Limited (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://tellurisbiotech.com/">https://tellurisbiotech.com/</uri>). All other authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</p></notes><ref-list><title>References</title><ref id="B1-molecules-30-03624"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hugot</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Baujard</surname><given-names>P.</given-names></name><name name-style="western"><surname>Morand</surname><given-names>S.</given-names></name></person-group><article-title>Biodiversity in helminths and nematodes as a field of study: An overview</article-title><source>Nematology</source><year>2001</year><volume>3</volume><fpage>199</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1163/156854101750413270</pub-id></element-citation></ref><ref id="B2-molecules-30-03624"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chitwood</surname><given-names>D.J.</given-names></name></person-group><article-title>Research on plant-parasitic nematode biology conducted by the United States Department of Agriculture&#8211;Agricultural Research Service</article-title><source>Pest. Manag. Sci.</source><year>2003</year><volume>59</volume><fpage>748</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1002/ps.684</pub-id><pub-id pub-id-type="pmid">12846325</pub-id></element-citation></ref><ref id="B3-molecules-30-03624"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trudgill</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Blok</surname><given-names>V.C.</given-names></name></person-group><article-title>Apomictic, polyphagous root-knot nematodes: Exceptionally successful and damaging biotrophic root pathogens</article-title><source>Annu. Rev. Phytopathol.</source><year>2001</year><volume>39</volume><fpage>53</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1146/annurev.phyto.39.1.53</pub-id><pub-id pub-id-type="pmid">11701859</pub-id></element-citation></ref><ref id="B4-molecules-30-03624"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elling</surname><given-names>A.A.</given-names></name></person-group><article-title>Major emerging problems with minor meloidogyne species</article-title><source>Phytopathology</source><year>2013</year><volume>103</volume><fpage>1092</fpage><lpage>1102</lpage><pub-id pub-id-type="doi">10.1094/PHYTO-01-13-0019-RVW</pub-id><pub-id pub-id-type="pmid">23777404</pub-id></element-citation></ref><ref id="B5-molecules-30-03624"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodell</surname><given-names>P.B.</given-names></name><name name-style="western"><surname>Ferris</surname><given-names>H.</given-names></name></person-group><article-title>Influence of Environmental Factors on the Hatch and Survival of Meloidogyne incognita</article-title><source>J. Nematol.</source><year>1989</year><volume>21</volume><fpage>328</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">19287616</pub-id><pub-id pub-id-type="pmcid">PMC2618941</pub-id></element-citation></ref><ref id="B6-molecules-30-03624"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdel-Rahman</surname><given-names>F.H.</given-names></name><name name-style="western"><surname>Alaniz</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Saleh</surname><given-names>M.A.</given-names></name></person-group><article-title>Nematicidal activity of terpenoids</article-title><source>J. Env. Environ. Sci. Health B</source><year>2013</year><volume>48</volume><fpage>16</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1080/03601234.2012.716686</pub-id><pub-id pub-id-type="pmid">23030436</pub-id></element-citation></ref><ref id="B7-molecules-30-03624"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burow</surname><given-names>K.R.</given-names></name><name name-style="western"><surname>Dubrovsky</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Shelton</surname><given-names>J.L.</given-names></name></person-group><article-title>Temporal trends in concentrations of DBCP and nitrate in groundwater in the eastern San Joaquin Valley, California, USA</article-title><source>Hydrogeol. J.</source><year>2007</year><volume>15</volume><fpage>991</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1007/s10040-006-0148-7</pub-id></element-citation></ref><ref id="B8-molecules-30-03624"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zaki</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Moran</surname><given-names>D.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>D.</given-names></name></person-group><article-title>Pesticides in groundwater: The aldicarb story in Suffolk County, NY</article-title><source>Am. J. Public. Health</source><year>1982</year><volume>72</volume><fpage>1391</fpage><lpage>1395</lpage><pub-id pub-id-type="doi">10.2105/AJPH.72.12.1391</pub-id><pub-id pub-id-type="pmid">7137437</pub-id><pub-id pub-id-type="pmcid">PMC1650561</pub-id></element-citation></ref><ref id="B9-molecules-30-03624"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiang-Qian</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jun-Zhi</surname><given-names>W.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Aroian</surname><given-names>R.V.</given-names></name></person-group><article-title>Resistance to root-knot nematode in tomato roots expressing a nematicidal Bacillus thuringiensis crystal protein</article-title><source>Plant Biotechnol. J.</source><year>2007</year><volume>5</volume><fpage>455</fpage><lpage>464</lpage><pub-id pub-id-type="pmid">17451491</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1467-7652.2007.00257.x</pub-id></element-citation></ref><ref id="B10-molecules-30-03624"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nunes</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Campos</surname><given-names>V.P.</given-names></name><name name-style="western"><surname>Mascarello</surname><given-names>A.</given-names></name><name name-style="western"><surname>Stumpf</surname><given-names>T.R.</given-names></name><name name-style="western"><surname>Chiaradia-Delatorre</surname><given-names>L.D.</given-names></name><name name-style="western"><surname>Machado</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Santos Junior</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Yunes</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Nunes</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>D.F.</given-names></name></person-group><article-title>Activity of chalcones derived from 2,4,5-trimethoxybenzaldehyde against Meloidogyne exigua and in silico interaction of one chalcone with a putative caffeic acid 3-O-methyltransferase from Meloidogyne incognita</article-title><source>Exp. Parasitol.</source><year>2013</year><volume>135</volume><fpage>661</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2013.10.003</pub-id><pub-id pub-id-type="pmid">24140596</pub-id></element-citation></ref><ref id="B11-molecules-30-03624"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Est&#233;vez-Braun</surname><given-names>A.</given-names></name></person-group><article-title>Effect of (E)-Chalcone on Potato-Cyst Nematodes (Globodera pallida and G. rostochiensis)</article-title><source>J. Agric. Food Chem.</source><year>1998</year><volume>46</volume><fpage>1163</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1021/jf9706686</pub-id></element-citation></ref><ref id="B12-molecules-30-03624"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimura</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hiraoka</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kawano</surname><given-names>T.</given-names></name><name name-style="western"><surname>Fujioka</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shimada</surname><given-names>A.</given-names></name></person-group><article-title>Nematicidal Activities of Acetylene Compounds from <italic toggle="yes">Coreopsis lanceolata</italic> L.</article-title><source>Z. Naturforschung C</source><year>2008</year><volume>63</volume><fpage>843</fpage><lpage>847</lpage><pub-id pub-id-type="doi">10.1515/znc-2008-11-1210</pub-id><pub-id pub-id-type="pmid">19227832</pub-id></element-citation></ref><ref id="B13-molecules-30-03624"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Attar</surname><given-names>S.</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Alhaddad</surname><given-names>H.</given-names></name><name name-style="western"><surname>Golden</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Calderon-Urrea</surname><given-names>A.</given-names></name></person-group><article-title>Ferrocenyl chalcones versus organic chalcones: A comparative study of their nematocidal activity</article-title><source>Bioorg Med. Chem.</source><year>2011</year><volume>19</volume><fpage>2055</fpage><lpage>2073</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2011.01.048</pub-id><pub-id pub-id-type="pmid">21349727</pub-id></element-citation></ref><ref id="B14-molecules-30-03624"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Das</surname><given-names>S.K.</given-names></name></person-group><article-title>Scope and relevance of using pesticide mixtures in crop protection: A critical review</article-title><source>Int. J. Env. Environ. Sci. Toxicol.</source><year>2014</year><volume>2</volume><fpage>119</fpage><lpage>123</lpage></element-citation></ref><ref id="B15-molecules-30-03624"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cedergreen</surname><given-names>N.</given-names></name></person-group><article-title>Quantifying synergy: A systematic review of mixture toxicity studies within environmental toxicology</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e96580</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0096580</pub-id><pub-id pub-id-type="pmid">24794244</pub-id><pub-id pub-id-type="pmcid">PMC4008607</pub-id></element-citation></ref><ref id="B16-molecules-30-03624"><label>16.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Chou</surname><given-names>T.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>N.</given-names></name></person-group><source>A Computer Program for Quantitation of Synergism and Antagonism in Drug Combinations, and the Determination of IC50 and ED50 and LD50 Values. CompuSyn for Drug Combinations: PC Software and User&#8217;s Guide</source><publisher-name>ComboSyn, Inc.</publisher-name><publisher-loc>Paramus, NJ, USA</publisher-loc><year>2005</year></element-citation></ref><ref id="B17-molecules-30-03624"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fierer</surname><given-names>N.</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>R.B.</given-names></name></person-group><article-title>The diversity and biogeography of soil bacterial communities</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2006</year><volume>103</volume><fpage>626</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1073/pnas.0507535103</pub-id><pub-id pub-id-type="pmid">16407148</pub-id><pub-id pub-id-type="pmcid">PMC1334650</pub-id></element-citation></ref><ref id="B18-molecules-30-03624"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zornoza</surname><given-names>R.</given-names></name><name name-style="western"><surname>Guerrero</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mataix-Solera</surname><given-names>J.</given-names></name><name name-style="western"><surname>Scow</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Arcenegui</surname><given-names>V.</given-names></name><name name-style="western"><surname>Mataix-Beneyto</surname><given-names>J.</given-names></name></person-group><article-title>Changes in soil microbial community structure following the abandonment of agricultural terraces in mountainous areas of Eastern Spain</article-title><source>Appl. Soil. Ecol.</source><year>2009</year><volume>42</volume><fpage>315</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1016/j.apsoil.2009.05.011</pub-id><pub-id pub-id-type="pmid">22291451</pub-id><pub-id pub-id-type="pmcid">PMC3267902</pub-id></element-citation></ref><ref id="B19-molecules-30-03624"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chou</surname><given-names>T.-C.</given-names></name><name name-style="western"><surname>Talalay</surname><given-names>P.</given-names></name></person-group><article-title>Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors</article-title><source>Adv. Enzym. Regul.</source><year>1984</year><volume>22</volume><fpage>27</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/0065-2571(84)90007-4</pub-id><pub-id pub-id-type="pmid">6382953</pub-id></element-citation></ref><ref id="B20-molecules-30-03624"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chou</surname><given-names>T.-C.</given-names></name></person-group><article-title>Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies</article-title><source>Pharmacol. Rev.</source><year>2006</year><volume>58</volume><fpage>621</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1124/pr.58.3.10</pub-id><pub-id pub-id-type="pmid">16968952</pub-id></element-citation></ref><ref id="B21-molecules-30-03624"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karlsson Green</surname><given-names>K.</given-names></name><name name-style="western"><surname>Stenberg</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Lankinen</surname><given-names>A.</given-names></name></person-group><article-title>Making sense of Integrated Pest Management (IPM) in the light of evolution</article-title><source>Evol. Appl.</source><year>2020</year><volume>13</volume><fpage>1791</fpage><lpage>1805</lpage><pub-id pub-id-type="doi">10.1111/eva.13067</pub-id><pub-id pub-id-type="pmid">32908586</pub-id><pub-id pub-id-type="pmcid">PMC7463341</pub-id></element-citation></ref><ref id="B22-molecules-30-03624"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stielow</surname><given-names>M.</given-names></name><name name-style="western"><surname>Witczynska</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kubryn</surname><given-names>N.</given-names></name><name name-style="western"><surname>Fijalkowski</surname><given-names>L.</given-names></name><name name-style="western"><surname>Nowaczyk</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nowaczyk</surname><given-names>A.</given-names></name></person-group><article-title>The Bioavailability of Drugs-The Current State of Knowledge</article-title><source>Molecules</source><year>2023</year><volume>28</volume><elocation-id>8038</elocation-id><pub-id pub-id-type="doi">10.3390/molecules28248038</pub-id><pub-id pub-id-type="pmid">38138529</pub-id><pub-id pub-id-type="pmcid">PMC10745386</pub-id></element-citation></ref><ref id="B23-molecules-30-03624"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Campos</surname><given-names>V.P.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>D.F.</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>V.A.</given-names></name><name name-style="western"><surname>Barros</surname><given-names>A.F.</given-names></name><name name-style="western"><surname>Din</surname><given-names>Z.U.</given-names></name><name name-style="western"><surname>Rodrigues-Filho</surname><given-names>E.</given-names></name></person-group><article-title>Chalcone analogues: Synthesis, activity against Meloidogyne incognita, and in silico interaction with cytochrome P450</article-title><source>J. Phytopathol.</source><year>2019</year><volume>167</volume><fpage>197</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1111/jph.12787</pub-id></element-citation></ref><ref id="B24-molecules-30-03624"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>&#538;opa</surname><given-names>D.-C.</given-names></name><name name-style="western"><surname>C&#259;p&#537;un&#259;</surname><given-names>S.</given-names></name><name name-style="western"><surname>Calistru</surname><given-names>A.-E.</given-names></name><name name-style="western"><surname>Ailinc&#259;i</surname><given-names>C.</given-names></name></person-group><article-title>Sustainable Practices for Enhancing Soil Health and Crop Quality in Modern Agriculture: A Review</article-title><source>Agriculture</source><year>2025</year><volume>15</volume><elocation-id>998</elocation-id><pub-id pub-id-type="doi">10.3390/agriculture15090998</pub-id></element-citation></ref><ref id="B25-molecules-30-03624"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daraban</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Hlihor</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Suteu</surname><given-names>D.</given-names></name></person-group><article-title>Pesticides vs. Biopesticides: From Pest Management to Toxicity and Impacts on the Environment and Human Health</article-title><source>Toxics</source><year>2023</year><volume>11</volume><elocation-id>983</elocation-id><pub-id pub-id-type="doi">10.3390/toxics11120983</pub-id><pub-id pub-id-type="pmid">38133384</pub-id><pub-id pub-id-type="pmcid">PMC10748064</pub-id></element-citation></ref><ref id="B26-molecules-30-03624"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bolyen</surname><given-names>E.</given-names></name><name name-style="western"><surname>Rideout</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Dillon</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Bokulich</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Abnet</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Al-Ghalith</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>H.</given-names></name><name name-style="western"><surname>Alm</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Arumugam</surname><given-names>M.</given-names></name><name name-style="western"><surname>Asnicar</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2</article-title><source>Nat. Biotechnol.</source><year>2019</year><volume>37</volume><fpage>852</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0209-9</pub-id><pub-id pub-id-type="pmid">31341288</pub-id><pub-id pub-id-type="pmcid">PMC7015180</pub-id></element-citation></ref><ref id="B27-molecules-30-03624"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tristan</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jovanovic</surname><given-names>V.M.</given-names></name><name name-style="western"><surname>Malley</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>P.H.</given-names></name><name name-style="western"><surname>Ryu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ormanoglu</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tao</surname><given-names>D.</given-names></name><etal/></person-group><article-title>A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells</article-title><source>Nat. Methods</source><year>2021</year><volume>18</volume><fpage>528</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1038/s41592-021-01126-2</pub-id><pub-id pub-id-type="pmid">33941937</pub-id><pub-id pub-id-type="pmcid">PMC8314867</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="molecules-30-03624-f001" orientation="portrait"><label>Figure 1</label><caption><p>Molecular structure of Chalcones <bold>17</bold>, <bold>25</bold> and <bold>30</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03624-g001.jpg"/></fig><fig position="float" id="molecules-30-03624-f002" orientation="portrait"><label>Figure 2</label><caption><p>Percent mortality in <italic toggle="yes">C. elegans</italic> caused by Chalcone <bold>17</bold> (<bold>A</bold>), Chalcone <bold>25</bold> (<bold>B</bold>) and Chalcone <bold>30</bold> (<bold>C</bold>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03624-g002.jpg"/></fig><fig position="float" id="molecules-30-03624-f003" orientation="portrait"><label>Figure 3</label><caption><p>Percent mortality in <italic toggle="yes">M. incognita</italic> caused by Chalcone <bold>17</bold> (<bold>A</bold>), Chalcone <bold>25</bold> (<bold>B</bold>) and Chalcone <bold>30</bold> (<bold>C</bold>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03624-g003.jpg"/></fig><fig position="float" id="molecules-30-03624-f004" orientation="portrait"><label>Figure 4</label><caption><p>Polygonograms showing the interactions of three chalcones in binary combinations at four effect levels: (<bold>A</bold>) fa = 0.3, (<bold>B</bold>) fa = 0.5, (<bold>C</bold>) fa = 0.75, and (<bold>D</bold>) fa = 0.9. The interactions were calculated by CompuSyn 3.0.1 for <italic toggle="yes">M. incognita</italic>. Solid lines (green) indicate synergism, broken lines (red) indicate antagonism, and the thickness of the line represents the strength of synergism or antagonism. The figure shows synergistic interactions of (<bold>25</bold> + <bold>30</bold>) all over fa values, while combination (<bold>17</bold> + <bold>25</bold>) and (<bold>17</bold> + <bold>30</bold>) showing a dual synergistic/antagonistic interactions at low and high effect values, respectively.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03624-g004.jpg"/></fig><fig position="float" id="molecules-30-03624-f005" orientation="portrait"><label>Figure 5</label><caption><p>Bacterial diversity among sample treatments. The figure shows two boxplots representing the Observed OTU&#8217;s (<bold>A</bold>) and the Shannon index (<bold>B</bold>) of samples aggregated by sample treatment. The &#8220;Control&#8221; indicates a solvent control.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03624-g005.jpg"/></fig><fig position="float" id="molecules-30-03624-f006" orientation="portrait"><label>Figure 6</label><caption><p>Graph representing the Beta Diversity results calculated using the Non-Metric Dimensional System (NMDS) ordination of Bray&#8211;Curtis Distances at t = 0, t = 48 and t = 96 h in the presence of chalcones <bold>17</bold>, <bold>25</bold>, <bold>30</bold> and their combinations.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03624-g006.jpg"/></fig><fig position="float" id="molecules-30-03624-f007" orientation="portrait"><label>Figure 7</label><caption><p>(<bold>A</bold>) effects of single chalcones on hPSCs and (<bold>B</bold>) effects of the chalcone <bold>17</bold> and chalcone <bold>30</bold> combination on hPSCs. n = 8. Error bar, mean &#177; SEM, one-way ANOVA with Dunnett&#8217;s multiple comparisons test, ** <italic toggle="yes">p</italic> &lt; 0.01, **** <italic toggle="yes">p</italic> &lt; 0.0001.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03624-g007.jpg"/></fig><table-wrap position="float" id="molecules-30-03624-t001" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03624-t001_Table 1</object-id><label>Table 1</label><caption><p>Percent mortality of individual, binary and ternary combinations of chalcones in <italic toggle="yes">C. elegans</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="8" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Percent Mortality of Individual and Chalcone Combinations</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#181;M</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 + 25</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 + 30</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 + 30</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 + 25 + 30</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">M9</td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">7%</td><td align="center" valign="middle" rowspan="1" colspan="1">8%</td><td align="center" valign="middle" rowspan="1" colspan="1">10%</td><td align="center" valign="middle" rowspan="1" colspan="1">7%</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">62</td><td align="center" valign="middle" rowspan="1" colspan="1">81</td><td align="center" valign="middle" rowspan="1" colspan="1">78</td><td align="center" valign="middle" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" rowspan="1" colspan="1">100%</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">38</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">97%</td><td align="center" valign="middle" rowspan="1" colspan="1">99%</td><td align="center" valign="middle" rowspan="1" colspan="1">96%</td><td align="center" valign="middle" rowspan="1" colspan="1">97%</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">31</td><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">44</td><td align="center" valign="middle" rowspan="1" colspan="1">99%</td><td align="center" valign="middle" rowspan="1" colspan="1">99%</td><td align="center" valign="middle" rowspan="1" colspan="1">99%</td><td align="center" valign="middle" rowspan="1" colspan="1">99%</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">37</td><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">28</td><td align="center" valign="middle" rowspan="1" colspan="1">99%</td><td align="center" valign="middle" rowspan="1" colspan="1">97%</td><td align="center" valign="middle" rowspan="1" colspan="1">93%</td><td align="center" valign="middle" rowspan="1" colspan="1">99%</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">35</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">93%</td><td align="center" valign="middle" rowspan="1" colspan="1">94%</td><td align="center" valign="middle" rowspan="1" colspan="1">94%</td><td align="center" valign="middle" rowspan="1" colspan="1">97%</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">94%</td><td align="center" valign="middle" rowspan="1" colspan="1">97%</td><td align="center" valign="middle" rowspan="1" colspan="1">92%</td><td align="center" valign="middle" rowspan="1" colspan="1">97%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">89%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">92%</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-30-03624-t002" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03624-t002_Table 2</object-id><label>Table 2</label><caption><p>Percentage mortality at day 5 in binary and ternary combinations of chalcones for <italic toggle="yes">M. incognita</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="9" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Mean Mortality at Day 5</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#181;M</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Solvent Control</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 + 25 + 30</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 + 25</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 + 30</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 + 30</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Control</td><td align="center" valign="middle" rowspan="1" colspan="1">30.98</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">83.61</td><td align="center" valign="middle" rowspan="1" colspan="1">95</td><td align="center" valign="middle" rowspan="1" colspan="1">97.61</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">83.22</td><td align="center" valign="middle" rowspan="1" colspan="1">71.35</td><td align="center" valign="middle" rowspan="1" colspan="1">97.05</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">88.65</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">73.09</td><td align="center" valign="middle" rowspan="1" colspan="1">50.68</td><td align="center" valign="middle" rowspan="1" colspan="1">88.33</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">86.07</td><td align="center" valign="middle" rowspan="1" colspan="1">99.01</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">68.58</td><td align="center" valign="middle" rowspan="1" colspan="1">46.32</td><td align="center" valign="middle" rowspan="1" colspan="1">84.11</td><td align="center" valign="middle" rowspan="1" colspan="1">99.11</td><td align="center" valign="middle" rowspan="1" colspan="1">79.27</td><td align="center" valign="middle" rowspan="1" colspan="1">90.32</td><td align="center" valign="middle" rowspan="1" colspan="1">96.10</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">66.36</td><td align="center" valign="middle" rowspan="1" colspan="1">36.90</td><td align="center" valign="middle" rowspan="1" colspan="1">67.35</td><td align="center" valign="middle" rowspan="1" colspan="1">88.90</td><td align="center" valign="middle" rowspan="1" colspan="1">65.55</td><td align="center" valign="middle" rowspan="1" colspan="1">76.93</td><td align="center" valign="middle" rowspan="1" colspan="1">85.01</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">61.37</td><td align="center" valign="middle" rowspan="1" colspan="1">38.12</td><td align="center" valign="middle" rowspan="1" colspan="1">50.36</td><td align="center" valign="middle" rowspan="1" colspan="1">65.91</td><td align="center" valign="middle" rowspan="1" colspan="1">52.90</td><td align="center" valign="middle" rowspan="1" colspan="1">55.85</td><td align="center" valign="middle" rowspan="1" colspan="1">66.06</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">59.42</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30.88</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.08</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51.72</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-30-03624-t003" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03624-t003_Table 3</object-id><label>Table 3</label><caption><p>The dose-effect curve parameters (Dm, m and r) of the individual chalcone and their binary and ternary combinations, as well as the mean combination index (CI) values of the combinations.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="3" align="center" valign="middle" style="border:solid thin" rowspan="1">Dose-Effect Parameters</th><th colspan="5" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">CI Values (Simulation)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chalcone Mixtures</th><th align="center" valign="middle" style="border-bottom:solid thin;border-left:solid thin" rowspan="1" colspan="1">Dm</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">m</th><th align="center" valign="middle" style="border-bottom:solid thin;border-right:solid thin" rowspan="1" colspan="1">r</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LD30</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LD50</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LD75</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LD90</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LD95</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>17</bold>
</td><td align="center" valign="middle" style="border-left:solid thin" rowspan="1" colspan="1">0.52866</td><td align="center" valign="middle" rowspan="1" colspan="1">0.49929</td><td align="center" valign="middle" style="border-right:solid thin" rowspan="1" colspan="1">0.91179</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>25</bold>
</td><td align="center" valign="middle" style="border-left:solid thin" rowspan="1" colspan="1">2.69874</td><td align="center" valign="middle" rowspan="1" colspan="1">1.13849</td><td align="center" valign="middle" style="border-right:solid thin" rowspan="1" colspan="1">0.75109</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>30</bold>
</td><td align="center" valign="middle" style="border-left:solid thin" rowspan="1" colspan="1">1.17503</td><td align="center" valign="middle" rowspan="1" colspan="1">1.55255</td><td align="center" valign="middle" style="border-right:solid thin" rowspan="1" colspan="1">0.96473</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>17</bold> + <bold>25</bold></td><td align="center" valign="middle" style="border-left:solid thin" rowspan="1" colspan="1">1.25970</td><td align="center" valign="middle" rowspan="1" colspan="1">1.51818</td><td align="center" valign="middle" style="border-right:solid thin" rowspan="1" colspan="1">0.84971</td><td align="center" valign="middle" rowspan="1" colspan="1">4.00226</td><td align="center" valign="middle" rowspan="1" colspan="1">1.42478</td><td align="center" valign="middle" rowspan="1" colspan="1">0.45544</td><td align="center" valign="middle" rowspan="1" colspan="1">0.20618</td><td align="center" valign="middle" rowspan="1" colspan="1">0.14499</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>25</bold> + <bold>30</bold></td><td align="center" valign="middle" style="border-left:solid thin" rowspan="1" colspan="1">1.10784</td><td align="center" valign="middle" rowspan="1" colspan="1">2.57209</td><td align="center" valign="middle" style="border-right:solid thin" rowspan="1" colspan="1">0.89924</td><td align="center" valign="middle" rowspan="1" colspan="1">0.89603</td><td align="center" valign="middle" rowspan="1" colspan="1">0.67666</td><td align="center" valign="middle" rowspan="1" colspan="1">0.47598</td><td align="center" valign="middle" rowspan="1" colspan="1">0.33901</td><td align="center" valign="middle" rowspan="1" colspan="1">0.27084</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>17</bold> + <bold>30</bold></td><td align="center" valign="middle" style="border-left:solid thin" rowspan="1" colspan="1">0.96596</td><td align="center" valign="middle" rowspan="1" colspan="1">3.10792</td><td align="center" valign="middle" style="border-right:solid thin" rowspan="1" colspan="1">0.95207</td><td align="center" valign="middle" rowspan="1" colspan="1">4.33634</td><td align="center" valign="middle" rowspan="1" colspan="1">1.32462</td><td align="center" valign="middle" rowspan="1" colspan="1">0.43256</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22516</td><td align="center" valign="middle" rowspan="1" colspan="1">0.16558</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>17</bold> + <bold>25</bold> + <bold>30</bold></td><td align="center" valign="middle" style="border-bottom:solid thin;border-left:solid thin" rowspan="1" colspan="1">0.85329</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.04931</td><td align="center" valign="middle" style="border-bottom:solid thin;border-right:solid thin" rowspan="1" colspan="1">0.97873</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.70836</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.88547</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.31404</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.16586</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12014</td></tr></tbody></table><table-wrap-foot><fn><p>Note: The parameters m, Dm (LD<sub>50</sub>) and r are the antilog of x-intercept, the slope and the linear correlation coefficient of the median&#8211;effect plot, which signifies the shape of the dose&#8211;effect curve, the effectiveness (LD<sub>50</sub>), and conformity of the data to the mass-action law, respectively (Chou and Talalay, 1984 [<xref rid="B19-molecules-30-03624" ref-type="bibr">19</xref>]; Chou, 2006 [<xref rid="B20-molecules-30-03624" ref-type="bibr">20</xref>]). LD<sub>50</sub> and m are used for calculating the CI values; CI &lt; 1, CI = 1, and CI &gt; 1 indicate synergism, additive effect, and antagonism, respectively. LD<sub>30</sub>, LD<sub>50</sub>, LD<sub>75</sub>, LD<sub>90</sub> and LD<sub>95</sub> are the doses required to reach a response mortality of 30%, 50%, 75%, and 90%, respectively.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="molecules-30-03624-t004" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03624-t004_Table 4</object-id><label>Table 4</label><caption><p>CI values and their significance at actual data points.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">CI Value</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Significance of CI Values</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Conc. &#181;M</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 + 25 + 30</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 + 25</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 + 30</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 + 30</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03604</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03368</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25329</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04977</td><td align="center" valign="middle" rowspan="1" colspan="1">strong synergy (CI &lt; 0.1)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02884</td><td align="center" valign="middle" rowspan="1" colspan="1">0.39745</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04325</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03982</td><td align="center" valign="middle" rowspan="1" colspan="1">synergy (0.1 &gt; CI &lt; 0.9)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02163</td><td align="center" valign="middle" rowspan="1" colspan="1">0.37529</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15197</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02986</td><td align="center" valign="middle" rowspan="1" colspan="1">additive (0.9 &gt; CI &lt; 1.1)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06780</td><td align="center" valign="middle" rowspan="1" colspan="1">0.49777</td><td align="center" valign="middle" rowspan="1" colspan="1">0.52095</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22629</td><td align="center" valign="middle" rowspan="1" colspan="1">antagonism (1.1 &gt; CI &lt; 10)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.20610</td><td align="center" valign="middle" rowspan="1" colspan="1">0.76261</td><td align="center" valign="middle" rowspan="1" colspan="1">0.53968</td><td align="center" valign="middle" rowspan="1" colspan="1">0.33706</td><td align="center" valign="middle" rowspan="1" colspan="1">strong antagonism (CI &gt; 10)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.42104</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.97838</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.52926</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.52809</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-30-03624-t005" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03624-t005_Table 5</object-id><label>Table 5</label><caption><p>Representing the average and standard deviation of Alpha diversity measured by the OTUs observed at t = 0, t = 48 and t = 96 h in the presence of chalcones <bold>17</bold>, <bold>25</bold>, <bold>30</bold> and their combinations. The &#8220;Control&#8221; indicates a solvent control. Abbreviations: AVG: average; STD: standard deviation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="5" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Observed OTUs</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatments</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">t = 0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">t = 48</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">t = 96</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AVG</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STD</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Control</td><td align="center" valign="middle" rowspan="1" colspan="1">2478</td><td align="center" valign="middle" rowspan="1" colspan="1">2334</td><td align="center" valign="middle" rowspan="1" colspan="1">2121</td><td align="center" valign="middle" rowspan="1" colspan="1">2311</td><td align="center" valign="middle" rowspan="1" colspan="1">179</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fluopyram</td><td align="center" valign="middle" rowspan="1" colspan="1">2519</td><td align="center" valign="middle" rowspan="1" colspan="1">2377</td><td align="center" valign="middle" rowspan="1" colspan="1">2317</td><td align="center" valign="middle" rowspan="1" colspan="1">2404</td><td align="center" valign="middle" rowspan="1" colspan="1">104</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mix (<bold>17</bold> + <bold>25</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">2493</td><td align="center" valign="middle" rowspan="1" colspan="1">2383</td><td align="center" valign="middle" rowspan="1" colspan="1">2115</td><td align="center" valign="middle" rowspan="1" colspan="1">2331</td><td align="center" valign="middle" rowspan="1" colspan="1">195</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mix (<bold>17</bold> + <bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">2542</td><td align="center" valign="middle" rowspan="1" colspan="1">2254</td><td align="center" valign="middle" rowspan="1" colspan="1">2307</td><td align="center" valign="middle" rowspan="1" colspan="1">2368</td><td align="center" valign="middle" rowspan="1" colspan="1">154</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mix (<bold>17</bold> + <bold>30</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">2594</td><td align="center" valign="middle" rowspan="1" colspan="1">2339</td><td align="center" valign="middle" rowspan="1" colspan="1">2261</td><td align="center" valign="middle" rowspan="1" colspan="1">2398</td><td align="center" valign="middle" rowspan="1" colspan="1">174</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mix (<bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">2489</td><td align="center" valign="middle" rowspan="1" colspan="1">2258</td><td align="center" valign="middle" rowspan="1" colspan="1">2246</td><td align="center" valign="middle" rowspan="1" colspan="1">2331</td><td align="center" valign="middle" rowspan="1" colspan="1">137</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nimitz</td><td align="center" valign="middle" rowspan="1" colspan="1">2422</td><td align="center" valign="middle" rowspan="1" colspan="1">2343</td><td align="center" valign="middle" rowspan="1" colspan="1">2204</td><td align="center" valign="middle" rowspan="1" colspan="1">2323</td><td align="center" valign="middle" rowspan="1" colspan="1">110</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">No Treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">2537</td><td align="center" valign="middle" rowspan="1" colspan="1">2625</td><td align="center" valign="middle" rowspan="1" colspan="1">2526</td><td align="center" valign="middle" rowspan="1" colspan="1">2563</td><td align="center" valign="middle" style="background:#FFC7CE" rowspan="1" colspan="1">
<named-content content-type="color:#9C0006">55</named-content>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ch. <bold>17</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">2485</td><td align="center" valign="middle" rowspan="1" colspan="1">2449</td><td align="center" valign="middle" rowspan="1" colspan="1">2287</td><td align="center" valign="middle" rowspan="1" colspan="1">2407</td><td align="center" valign="middle" rowspan="1" colspan="1">105</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ch. <bold>25</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">2424</td><td align="center" valign="middle" rowspan="1" colspan="1">2212</td><td align="center" valign="middle" rowspan="1" colspan="1">2341</td><td align="center" valign="middle" rowspan="1" colspan="1">2326</td><td align="center" valign="middle" rowspan="1" colspan="1">107</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch. <bold>30</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2469</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2361</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2196</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2342</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">138</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-30-03624-t006" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03624-t006_Table 6</object-id><label>Table 6</label><caption><p>Representing the average and standard deviation of Alpha diversity measured using the Shannon Diversity Index observed at t = 0, t = 48 and t = 96 h in the presence of chalcones <bold>17</bold>, <bold>25</bold>, <bold>30</bold> and their combinations. Abbreviations: AVG: average; STD: standard deviation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="5" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Shannon Diversity Index</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatments</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">t = 0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">t = 48</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">t = 96</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AVG</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STD</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Control</td><td align="center" valign="middle" rowspan="1" colspan="1">6.60</td><td align="center" valign="middle" rowspan="1" colspan="1">6.56</td><td align="center" valign="middle" rowspan="1" colspan="1">6.11</td><td align="center" valign="middle" rowspan="1" colspan="1">6.42</td><td align="center" valign="middle" rowspan="1" colspan="1">0.27</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fluopyram</td><td align="center" valign="middle" rowspan="1" colspan="1">6.69</td><td align="center" valign="middle" rowspan="1" colspan="1">6.67</td><td align="center" valign="middle" rowspan="1" colspan="1">6.61</td><td align="center" valign="middle" rowspan="1" colspan="1">6.66</td><td align="center" valign="middle" style="background:#FFC7CE" rowspan="1" colspan="1">
<named-content content-type="color:#9C0006">0.04</named-content>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mix (<bold>17</bold> + <bold>25</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.65</td><td align="center" valign="middle" rowspan="1" colspan="1">6.56</td><td align="center" valign="middle" rowspan="1" colspan="1">5.88</td><td align="center" valign="middle" rowspan="1" colspan="1">6.36</td><td align="center" valign="middle" rowspan="1" colspan="1">0.42</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mix (<bold>17</bold> + <bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.76</td><td align="center" valign="middle" rowspan="1" colspan="1">6.37</td><td align="center" valign="middle" rowspan="1" colspan="1">6.36</td><td align="center" valign="middle" rowspan="1" colspan="1">6.50</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mix (<bold>17</bold> + <bold>30</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.73</td><td align="center" valign="middle" rowspan="1" colspan="1">6.59</td><td align="center" valign="middle" rowspan="1" colspan="1">6.17</td><td align="center" valign="middle" rowspan="1" colspan="1">6.50</td><td align="center" valign="middle" rowspan="1" colspan="1">0.29</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mix (<bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.75</td><td align="center" valign="middle" rowspan="1" colspan="1">6.42</td><td align="center" valign="middle" rowspan="1" colspan="1">6.25</td><td align="center" valign="middle" rowspan="1" colspan="1">6.47</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nimitz</td><td align="center" valign="middle" rowspan="1" colspan="1">6.31</td><td align="center" valign="middle" rowspan="1" colspan="1">6.56</td><td align="center" valign="middle" rowspan="1" colspan="1">6.42</td><td align="center" valign="middle" rowspan="1" colspan="1">6.43</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">No Treatment</td><td align="center" valign="middle" rowspan="1" colspan="1">6.66</td><td align="center" valign="middle" rowspan="1" colspan="1">6.79</td><td align="center" valign="middle" rowspan="1" colspan="1">6.73</td><td align="center" valign="middle" rowspan="1" colspan="1">6.73</td><td align="center" valign="middle" style="background:#FFC7CE" rowspan="1" colspan="1">
<named-content content-type="color:#9C0006">0.06</named-content>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ch. <bold>17</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">6.64</td><td align="center" valign="middle" rowspan="1" colspan="1">6.55</td><td align="center" valign="middle" rowspan="1" colspan="1">6.41</td><td align="center" valign="middle" rowspan="1" colspan="1">6.53</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ch. <bold>25</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">6.53</td><td align="center" valign="middle" rowspan="1" colspan="1">6.22</td><td align="center" valign="middle" rowspan="1" colspan="1">6.51</td><td align="center" valign="middle" rowspan="1" colspan="1">6.42</td><td align="center" valign="middle" rowspan="1" colspan="1">0.17</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch. <bold>30</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.54</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.51</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.41</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.21</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-30-03624-t007" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03624-t007_Table 7</object-id><label>Table 7</label><caption><p>Kruskal&#8211;Wallis Pairwise comparison between treatments (Shannon diversity values) indicating that the differences observed were not statistically significant.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Group 1</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Group 2</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Group 1</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Group 2</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>17</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>25</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>17</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>30</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2752</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8273</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>17</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8273</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8273</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>17</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC7CE" rowspan="1" colspan="1">
<named-content content-type="color:#9C0006">0.0495</named-content>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8273</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>17</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2752</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluopyram</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2752</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>17</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nimitz </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8273</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>17</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8273</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No Treatment</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC7CE" rowspan="1" colspan="1">
<named-content content-type="color:#9C0006">0.0495</named-content>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>17</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluopyram </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2752</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>17</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nimitz </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2752</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>17</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No Treatment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1266</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC7CE" rowspan="1" colspan="1">
<named-content content-type="color:#9C0006">0.0495</named-content>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>25</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>30</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8273</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluopyram </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC7CE" rowspan="1" colspan="1">
<named-content content-type="color:#9C0006">0.0495</named-content>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>25</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8273</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nimitz </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>25</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold>+<bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No Treatment</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC7CE" rowspan="1" colspan="1">
<named-content content-type="color:#9C0006">0.0495</named-content>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>25</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8273</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>25</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2752</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>25</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2752</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluopyram </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1266</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>25</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluopyram </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1266</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nimitz </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8273</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>25</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nimitz</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No Treatment </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC7CE" rowspan="1" colspan="1">
<named-content content-type="color:#9C0006">0.0495</named-content>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>25</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No Treatment</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC7CE" rowspan="1" colspan="1">
<named-content content-type="color:#9C0006">0.0495</named-content>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>30</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8273</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluopyram </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>30</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nimitz </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8273</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>30</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>17</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No Treatment </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>30</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch (<bold>25</bold> + <bold>30</bold>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluopyram </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5127</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>30</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2752</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nimitz </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2752</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>30</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluopyram</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1266</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No Treatment </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2752</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>30</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nimitz</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8273</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluopyram </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nimitz </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1266</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ch <bold>30</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No Treatment</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC7CE" rowspan="1" colspan="1">
<named-content content-type="color:#9C0006">0.0495</named-content>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluopyram </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No Treatment </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2752</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nimitz </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No Treatment </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#FFC7CE" rowspan="1" colspan="1">
<named-content content-type="color:#9C0006">0.0495</named-content>
</td></tr></tbody></table></table-wrap></floats-group></article></pmc-articleset>